Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AQST
Stock Latest News
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
7d ago
BE
GM
Premium
The Fly
Midday Fly By: Job growth comes in below forecasts in December
8d ago
C
Z
Premium
The Fly
ARS Pharmaceuticals competitor gets FDA deficiency letter, says Raymond James
8d ago
AQST
SPRY
Premium
The Fly
Morning Movers: Oklo, Vistra climb following Meta nuclear energy deals
8d ago
LDI
RKT
Premium
Market News
Why Is Aquestive Therapeutics Stock (AQST) Down Today?
8d ago
AQST
Premium
Company Announcements
Aquestive Faces FDA Deficiencies on Anaphylm NDA Review
8d ago
8K
AQST
Premium
The Fly
Aquestive announces FDA identified deficiencies in NDA for Anaphylm
8d ago
AQST
Premium
Ratings
Needle‑Free Anaphylaxis Treatments Poised for Growth: Physician Survey Supports Buy Rating on Aquestive’s Anaphylm (AQST)
9d ago
AQST
Premium
The Fly
Aquestive Therapeutics management to meet with Oppenheimer
2M ago
AQST
Premium
Ratings
Buy Rating for Aquestive Therapeutics Driven by Anaphylm’s FDA Approval Prospects and Market Potential
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics price target raised to $8 from $5 at Piper Sandler
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Reports Q3 2025 Financial Results
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics’ Earnings Call: Optimism Amid Challenges
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Advances Anaphylm Towards FDA Approval
2M ago
8K
AQST
Premium
Ratings
Positive Outlook for Aquestive Therapeutics: Buy Rating Driven by Strong Pipeline, Financial Position, and Upcoming PDUFA Date
2M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Reports Q3 2025 Financial Results
2M ago
8K
AQST
Premium
The Fly
Aquestive Therapeutics reports Q3 EPS (14c), consensus (11c)
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics cuts FY25 revenue view to $44M-$50M from $47M-$56M
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics options imply 14.6% move in share price post-earnings
2M ago
AQST
Premium
The Fly
Aquestive appoints Davis as CDO, Slatko as interim CMO, Boyd as CPO
2M ago
AQST
Premium
The Fly
Aquestive Therapeutics price target raised to $12 from $9 at Citizens JMP
3M ago
AQST
Premium
Company Announcements
Aquestive Therapeutics Secures New Patents for Anaphylm
3M ago
8K
AQST
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
